Comparative Economic Outcomes in Patients with Focal Seizure Initiating First-Line Eslicarbazepine Acetate Monotherapy versus Generic Antiseizure Drugs

OBJECTIVE: To examine the association between initiating first-line (1L) monotherapy with eslicarbazepine acetate (ESL) vs a generic antiseizure drug (ASD) and healthcare resource utilization (HCRU) and charges in adults with treated focal seizures (FS). METHODS: This was a retrospective analysis of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clinicoecon Outcomes Res
Päätekijät: Mehta, Darshan, Davis, Matthew, Epstein, Andrew J, Wensel, Brian, Grinnell, Todd, Williams, G Rhys
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove 2021
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8064618/
https://ncbi.nlm.nih.gov/pubmed/33907433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S303079
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia